Serum Activin A is not associated with carcinoid heart disease (CHD) in patients with neuroendocrine tumors (NET)

被引：0
|
作者：
Levy, S. [1 ]
Kilgallen, A. B. [2 ]
Korse, C. M. [1 ]
Oerlemans, M. J. F. [2 ]
Sluijter, J. P. G. [2 ]
Valk, G. D. [2 ]
van Laake, L. W. [2 ]
Tesselaar, M. E. T. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2022年 / 34卷
关键词：
chd; carcinoid heart disease; biomarker; nt-probnp; activin a;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F12
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [1] Managing carcinoid heart disease in patients with neuroendocrine tumors
    Koffas, Apostolos
    Toumpanakis, Christos
    ANNALES D ENDOCRINOLOGIE, 2021, 82 (3-4) : 187 - 192
  • [2] Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors An Expert Statement
    Davar, Joseph
    Connolly, Heidi M.
    Caplin, Martyn E.
    Pavel, Marianne
    Zacks, Jerome
    Bhattacharyya, Sanjeev
    Cuthbertson, Daniel J.
    Dobson, Rebecca
    Grozinsky-Glasberg, Simona
    Steeds, Richard P.
    Dreyfus, Giles
    Pellikka, Patricia A.
    Toumpanakis, Christos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (10) : 1288 - 1304
  • [3] Carcinoid Heart Disease in Patients Diagnosed with Small Bowel and Lung Neuroendocrine Tumors
    Duncan, Katrina
    Law, Calvin
    Singh, Simron
    Barabash, Victoria
    Myrehaug, Sten
    Ahmed, Shaheeda
    Chan, Wing
    Coburn, Natalie
    Hallet, Julie
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 435 - 436
  • [4] Carcinoid heart disease in patients with midgut neuroendocrine tumours
    Delhomme, Clemence
    Walter, Thomas
    Arangalage, Dimitri
    Suc, Gaspard
    Hentic, Olivia
    Cachier, Agnes
    Alkhoder, Soleiman
    Francois, Laurent
    Lombard-Bohas, Catherine
    Iung, Bernard
    Ruszniewski, Philippe
    de Mestier, Louis
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 (04)
  • [5] Carcinoid heart disease is associated with reduced survival in patients with carcinoid disease
    Wong, C. K. L.
    Ardill, J. E.
    Poston, G. J.
    Burgess, M. I.
    Pritchard, M.
    Thompson, P.
    Hofman, U.
    Valle, J. W.
    Anthoney, A.
    Cuthbertson, D. J.
    EUROPEAN HEART JOURNAL, 2011, 32 : 1089 - 1089
  • [6] Catheter Ablation in Patients With Neuroendocrine (Carcinoid) Tumors and Carcinoid Heart Disease Outcomes, Peri-Procedural Complications, and Management Strategies
    Shabtaie, Samuel A.
    Luis, Sushil Allen
    Ward, Robert C.
    Karki, Roshan
    Connolly, Heidi M.
    Pellikka, Patricia A.
    Kapa, Suraj
    Asirvatham, Samuel J.
    Packer, Douglas L.
    DeSimone, Christopher, V
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2021, 7 (02) : 151 - 160
  • [7] CARCINOID HEART DISEASE PREVALENCE AMONG PATIENTS WITH NEUROENDOCRINE TUMORS: THE MD ANDERSON CANCER CENTER EXPERIENCE
    Fossas, Jose
    Irizarry-Caro, Jorge A.
    Yarrabothula, Akshitha R.
    Hassan, Saamir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1926 - 1926
  • [8] Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors
    Beilei Cai
    Michael S Broder
    Eunice Chang
    Tingjian Yan
    David C Metz
    World Journal of Gastroenterology, 2017, (40) : 7283 - 7291
  • [9] Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors
    Cai, Beilei
    Broder, Michael S.
    Chang, Eunice
    Yan, Tingjian
    Metz, David C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (40) : 7283 - 7291
  • [10] Epidemiology of Carcinoid Heart Disease (CHD) in Patients (pts) with Carcinoid Syndrome (CS): A Systematic Literature Review
    Ovcinnikova, O.
    Marshall, M.
    Bagnati, F.
    Hoffmanns, P.
    Taveau, C.
    Nayroles, G.
    NEUROENDOCRINOLOGY, 2017, 105 : 50 - 50
12345